MBOT: Microbot Medical Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Microbot Medical Inc (MBOT).
$18.96M Market Cap.
MBOT Market Cap. (MRY)
MBOT Shares Outstanding (MRY)
MBOT Assets (MRY)
Total Assets
$6.03M
Total Liabilities
$2.50M
Total Investments
$2.36M
MBOT Income (MRY)
Revenue
$0
Net Income
-$11.44M
Operating Expense
$11.63M
MBOT Cash Flow (MRY)
CF Operations
-$8.83M
CF Investing
$1.54M
CF Financing
$7.94M
MBOT Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $6,031,000 (-27.57%) | $8,327,000 (-12.69%) | $9,537,000 (-43.12%) | $16,767,000 (-36.20%) |
Assets Current | $5,819,000 (-26.54%) | $7,921,000 (-10.13%) | $8,814,000 (-44.49%) | $15,879,000 (-37.12%) |
Assets Non-Current | $212,000 (-47.78%) | $406,000 (-43.85%) | $723,000 (-18.58%) | $888,000 (-13.45%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $3,530,000 (-21.57%) | $4,501,000 (-38.25%) | $7,289,000 (-49.32%) | $14,381,000 (-40.84%) |
Property Plant & Equipment Net | $212,000 (-47.78%) | $406,000 (-43.85%) | $723,000 (-18.58%) | $888,000 (-13.45%) |
Cash & Equivalents | $3,163,000 (25.67%) | $2,517,000 (-0.08%) | $2,519,000 (-81.45%) | $13,580,000 (-31.18%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $2,356,000 (-39.85%) | $3,917,000 (-32.03%) | $5,763,000 (188.29%) | $1,999,000 (-60.00%) |
Investments Current | $2,356,000 (-39.85%) | $3,917,000 (-32.03%) | $5,763,000 (188.29%) | $1,999,000 (-60.00%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $165,000 (-53.78%) | $357,000 (207.76%) | $116,000 (-58.42%) | $279,000 (1.45%) |
Accumulated Retained Earnings (Deficit) | -$90,944,000 (-14.39%) | -$79,501,000 (-15.62%) | -$68,761,000 (-23.69%) | -$55,593,000 (-25.55%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $111,000 (-51.95%) | $231,000 (-50.00%) | $462,000 (-32.06%) | $680,000 (-16.36%) |
Debt Current | $70,000 (-63.35%) | $191,000 (-32.51%) | $283,000 (1.80%) | $278,000 (48.66%) |
Debt Non-Current | $41,000 (2.50%) | $40,000 (-77.65%) | $179,000 (-55.47%) | $402,000 (-35.78%) |
Total Liabilities | $2,501,000 (-34.63%) | $3,826,000 (70.20%) | $2,248,000 (-5.78%) | $2,386,000 (21.06%) |
Liabilities Current | $2,460,000 (-35.02%) | $3,786,000 (82.99%) | $2,069,000 (4.28%) | $1,984,000 (47.51%) |
Liabilities Non-Current | $41,000 (2.50%) | $40,000 (-77.65%) | $179,000 (-55.47%) | $402,000 (-35.78%) |
MBOT Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $4,995,000 (20.92%) | $4,131,000 (-25.50%) | $5,545,000 (6.55%) | $5,204,000 (-8.59%) |
Research & Development Expense | $6,630,000 (15.83%) | $5,724,000 (-26.01%) | $7,736,000 (25.73%) | $6,153,000 (81.18%) |
Operating Expenses | $11,625,000 (17.94%) | $9,857,000 (-25.78%) | $13,281,000 (16.94%) | $11,357,000 (24.95%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$11,443,000 (-6.55%) | -$10,740,000 (18.44%) | -$13,168,000 (-16.40%) | -$11,313,000 (-23.38%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$11,443,000 (-6.55%) | -$10,740,000 (18.44%) | -$13,168,000 (-16.40%) | -$11,313,000 (-23.38%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$11,443,000 (-6.55%) | -$10,740,000 (18.44%) | -$13,168,000 (-16.40%) | -$11,313,000 (-23.38%) |
Weighted Average Shares | $15,644,511 (53.38%) | $10,199,984 (40.49%) | $7,260,344 (2.14%) | $7,108,133 (-0.14%) |
Weighted Average Shares Diluted | $15,644,511 (53.38%) | $10,199,984 (40.49%) | $7,260,344 (2.14%) | $7,108,133 (-0.14%) |
Earning Before Interest & Taxes (EBIT) | -$11,443,000 (-6.55%) | -$10,740,000 (18.44%) | -$13,168,000 (-16.40%) | -$11,313,000 (-23.38%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$11,625,000 (-17.94%) | -$9,857,000 (25.78%) | -$13,281,000 (-16.94%) | -$11,357,000 (-24.95%) |
MBOT Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $1,537,000 (-22.10%) | $1,973,000 (151.43%) | -$3,836,000 (-219.88%) | $3,200,000 (215.61%) |
Net Cash Flow from Financing | $7,936,000 (21.01%) | $6,558,000 (51.67%) | $4,324,000 (0%) | $0 (0%) |
Net Cash Flow from Operations | -$8,827,000 (-3.45%) | -$8,533,000 (26.11%) | -$11,549,000 (-23.47%) | -$9,354,000 (-28.99%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $646,000 (32400.00%) | -$2,000 (99.98%) | -$11,061,000 (-79.74%) | -$6,154,000 (54.06%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $1,562,000 (-22.13%) | $2,006,000 (153.46%) | -$3,752,000 (-214.78%) | $3,269,000 (222.11%) |
Capital Expenditure | -$25,000 (24.24%) | -$33,000 (60.71%) | -$84,000 (-21.74%) | -$69,000 (24.18%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $7,936,000 (21.01%) | $6,558,000 (51.67%) | $4,324,000 (0%) | $0 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $1,349,000 (-3.23%) | $1,394,000 (-20.43%) | $1,752,000 (26.41%) | $1,386,000 (-28.45%) |
Depreciation Amortization & Accretion | $91,000 (-14.15%) | $106,000 (3.92%) | $102,000 (34.21%) | $76,000 (11.76%) |
MBOT Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -234.00% (-42.60%) | -164.10% (-2.76%) | -159.70% (-163.53%) | -60.60% (-79.82%) |
Return on Average Assets (ROAA) | -175.80% (-40.42%) | -125.20% (2.11%) | -127.90% (-133.39%) | -54.80% (-72.33%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -356.70% (-31.14%) | -272.00% (40.95%) | -460.60% (-90.09%) | -242.30% (30.63%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.53 (1.79%) | -1.56 (6.07%) | -1.66 (64.74%) | -4.72 (11.68%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 5.37 (25.93%) | 4.27 (30.94%) | 3.26 (-12.11%) | 3.71 (83.97%) |
Debt to Equity Ratio (D/E) | 0.71 (-16.71%) | 0.85 (175.97%) | 0.31 (85.54%) | 0.17 (104.94%) |
Earnings Per Share (EPS) | -0.73 (30.48%) | -1.05 (41.99%) | -1.81 (-13.84%) | -1.59 (-23.26%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -0.57 (32.62%) | -0.84 (47.57%) | -1.6 (-20.81%) | -1.33 (-28.49%) |
Book Value Per Share (BVPS) | 0.23 (-48.75%) | 0.44 (-56.08%) | 1 (-50.37%) | 2.02 (-40.76%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.39 (-52.70%) | 0.82 (-37.90%) | 1.31 (-44.30%) | 2.36 (-36.11%) |
Enterprise Value Over EBIT (EV/EBIT) | -2 (0.00%) | -2 (0.00%) | -2 (50.00%) | -4 (-33.33%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.63 (3.94%) | -1.7 (-11.85%) | -1.52 (57.85%) | -3.6 (-41.50%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 2.37 (13.05%) | 2.09 (-50.89%) | 4.26 (-46.78%) | 8 (-57.37%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$8,852,000 (-3.34%) | -$8,566,000 (26.36%) | -$11,633,000 (-23.45%) | -$9,423,000 (-28.33%) |
Enterprise Value (EV) | $18,531,222 (2.59%) | $18,064,000 (-8.97%) | $19,843,790 (-51.01%) | $40,501,998 (74.74%) |
Earnings Before Tax (EBT) | -$11,443,000 (-6.55%) | -$10,740,000 (18.44%) | -$13,168,000 (-16.40%) | -$11,313,000 (-23.38%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$11,352,000 (-6.75%) | -$10,634,000 (18.61%) | -$13,066,000 (-16.28%) | -$11,237,000 (-23.47%) |
Invested Capital | $519,000 (-76.98%) | $2,255,000 (-58.33%) | $5,411,000 (187.36%) | $1,883,000 (-68.68%) |
Working Capital | $3,359,000 (-18.77%) | $4,135,000 (-38.70%) | $6,745,000 (-51.46%) | $13,895,000 (-41.88%) |
Tangible Asset Value | $6,031,000 (-27.57%) | $8,327,000 (-12.69%) | $9,537,000 (-43.12%) | $16,767,000 (-36.20%) |
Market Capitalization | $18,964,222 (-1.23%) | $19,200,000 (-19.16%) | $23,750,790 (-55.45%) | $53,310,998 (8.85%) |
Average Equity | $4,890,000 (-25.27%) | $6,543,750 (-20.64%) | $8,245,750 (-55.85%) | $18,674,750 (-31.37%) |
Average Assets | $6,510,000 (-24.10%) | $8,576,750 (-16.67%) | $10,292,500 (-50.10%) | $20,625,750 (-28.57%) |
Invested Capital Average | $3,208,250 (-18.74%) | $3,948,250 (38.11%) | $2,858,750 (-38.77%) | $4,668,750 (77.86%) |
Shares | 16,932,341 (44.63%) | 11,707,317 (48.37%) | 7,890,628 (11.01%) | 7,108,133 (0.00%) |
